PROTECT Series of Clinical Studies Provides Mounting Evidence for Impella Support in High-risk PCI

Looking at the data from the PROTECT Series—PROTECT I1, PROTECT II RCT2, and PROTECT III—William O’...

Contemporary Landscape of PCI and RESTORE EF

TCT 2019 Presentation from SCAI President Dr. Ehtisham Mahmud At TCT 2019, Dr. Ehtisham Mahmud gave a...

Value of Complete Revascularization in a Single Setting

Dr. Rajan Patel Presents Supporting Data at TCT 2019 “I’m going to talk about some compelling data demonstrating t...

Impella Support and Acute Kidney Injury During High-Risk PCI

Results from the cVAD Study™ on Renal Protection Dr. Michael Flaherty presents data on...

New PROTECT III Data Demonstrates Impella® Reduces MACCE at Primary Endpoint

Jeffrey J. Popma, MD, presents new data from ongoing FDA post-approval study for PROTECT II randomized control trial. &n...

What is Restore EF?

Impact on EF at 60-180 days after high-risk PCI with Impella® support Jason Wollmu...

New Clinical Publication: Long-Term Outcomes of Complex, High-Risk PCI Patients

Dr. Shon Chakrabarti shares information on a recent publication from the Journal of Interventional Cardiology by Dr. Francesco...